BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL

Vaccinations effectively prevent infections; however, patients with chronic lymphocytic leukemia (CLL) have reduced antibody responses following vaccinations. Combined humoral and cellular immune responses to novel adjuvanted vaccines are not well characterized in CLL. In an open-label, single-arm c...

Descripción completa

Detalles Bibliográficos
Autores principales: Pleyer, Christopher, Laing, Kerry J., Ali, Mir A., McClurkan, Christopher L., Soto, Susan, Ahn, Inhye E., Nierman, Pia, Maddux, Emeline, Lotter, Jennifer, Superata, Jeanine, Tian, Xin, Wiestner, Adrian, Cohen, Jeffrey I., Koelle, David M., Sun, Clare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941484/
https://www.ncbi.nlm.nih.gov/pubmed/35157769
http://dx.doi.org/10.1182/bloodadvances.2021006574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941484/
https://www.ncbi.nlm.nih.gov/pubmed/35157769
http://dx.doi.org/10.1182/bloodadvances.2021006574

Ejemplares similares